Eloxx Pharmaceuticals, Inc. (ELOX)
15.51
-0.20
(-1.27%)
USD |
OTCM |
Oct 02, 16:00
15.32
-0.19
(-1.23%)
After-Hours: 20:00
Eloxx Pharmaceuticals Gross Profit Margin (Quarterly)
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2015 | 0.00% |
| September 30, 2015 | 0.00% |
| June 30, 2015 | 0.00% |
| March 31, 2015 | 0.00% |
| December 31, 2014 | |
| September 30, 2014 | |
| June 30, 2014 | |
| March 31, 2014 | |
| December 31, 2013 | |
| September 30, 2013 | 0.00% |
| June 30, 2013 | |
| March 31, 2013 | |
| December 31, 2012 | |
| September 30, 2012 | |
| June 30, 2012 | |
| March 31, 2012 | |
| December 31, 2011 | 0.00% |
| September 30, 2011 | |
| June 30, 2011 | |
| March 31, 2011 | |
| December 31, 2010 | |
| September 30, 2010 | |
| June 30, 2010 | |
| March 31, 2010 | |
| December 31, 2009 | 0.00% |
| Date | Value |
|---|---|
| September 30, 2009 | |
| June 30, 2009 | |
| March 31, 2009 | 0.00% |
| December 31, 2008 | |
| September 30, 2008 | 0.00% |
| June 30, 2008 | |
| March 31, 2008 | 0.00% |
| December 31, 2007 | 0.00% |
| September 30, 2007 | 0.00% |
| June 30, 2007 | 0.00% |
| March 31, 2007 | 0.00% |
| December 31, 2006 | 0.00% |
| September 30, 2006 | 0.00% |
| June 30, 2006 | 0.00% |
| March 31, 2006 | 0.00% |
| December 31, 2005 | 0.00% |
| September 30, 2005 | 0.00% |
| June 30, 2005 | 0.00% |
| March 31, 2005 | 0.00% |
| December 31, 2004 | 0.00% |
| September 30, 2004 | 0.00% |
| June 30, 2004 | 0.00% |
| March 31, 2004 | 0.00% |
| December 31, 2003 | |
| September 30, 2003 |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| Filana Therapeutics, Inc. | -- |
| CorMedix, Inc. | 75.66% |
| BioStem Technologies, Inc. | 52.55% |
| Wave Life Sciences, Inc. | -4.27% |
| Axsome Therapeutics, Inc. | 92.47% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -28.62K% |
| Return on Assets | -65.48% |
| Return on Invested Capital | -455.8% |
| Return on Net Operating Assets | -1.13K% |